Slac2-b activators are a specialized group of chemicals that specifically target and modulate the function of the protein Slac2-b, which is known to be involved in intracellular signaling pathways. Slac2-b, also referred to as EXPH5 or exophilin-5, is a member of the Slac2 family of proteins, which are characterized by their role in the regulation of vesicle trafficking. The activators of Slac2-b typically bind to the protein at specific sites, leading to a conformational change that can increase the protein's activity. This activation process is crucial for the proper functioning of the protein in its cellular context. The chemical structure of these activators can vary widely, but they share the common feature of being able to interact with Slac2-b in a way that promotes its activation state.
These molecules exert their influence by facilitating the interaction of Slac2-b with other proteins or lipids within the cell, thereby impacting the dynamics of vesicle transport. The precise mechanisms by which Slac2-b activators exert their effects can depend on the structure of the activator molecule and the specific domain of the Slac2-b protein that is targeted. While some activators might mimic the effect of physiological ligands or protein partners, others might stabilize Slac2-b in an active conformation or enhance its association with membranes or cytoskeletal elements. The diversity of these activators reflects the complex regulatory environment of intracellular transport and signaling, wherein Slac2-b plays a pivotal role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin elevates cAMP levels by activating adenylyl cyclase. Elevated cAMP can influence exocytotic machinery, potentially increasing Slac2-b activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates PKC, a kinase involved in various cellular processes, including vesicle transport. PKC activation may enhance Slac2-b activity in vesicle transport. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Ionomycin raises intracellular calcium levels. Elevated calcium can promote exocytosis and may influence Slac2-b-mediated vesicle transport. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Br-cAMP, a cAMP analog, can influence vesicle transport machinery, which may modulate Slac2-b's role in the process. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
By chelating calcium, BAPTA-AM modulates calcium-mediated signaling. Altering calcium signaling can influence vesicle transport and Slac2-b's role therein. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, by inhibiting tyrosine kinases, can affect vesicle docking and fusion events, possibly modulating Slac2-b activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93, an inhibitor of CaMKII, affects calcium-dependent processes like vesicle exocytosis, potentially influencing Slac2-b's role. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 elevates intracellular calcium levels, which can affect vesicle exocytosis and Slac2-b's role in the process. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
ML-7 inhibits myosin light chain kinase (MLCK), affecting actin-myosin interactions. Changes here can potentially affect Slac2-b-mediated transport processes. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A disrupts actin filaments. Changes in the actin cytoskeleton can influence vesicle transport and Slac2-b's role in this process. | ||||||